Literature DB >> 2524402

The effects of beta-endorphin on arginine-8-vasopressin and oxytocin levels in rat brain areas.

M Vecsernyés1, F Laczi, G L Kovács, G Szabó, T Janáky, G Telegdy, F A László.   

Abstract

Measurements were made of the effects of intracerebroventricular treatment with beta-endorphin (BE; 100 ng) on the arginine-8-vasopressin (AVP) and oxytocin contents of rat hypothalamic and limbic brain areas (hippocampus, amygdala and septum). The hormone concentrations were determined by radioimmunoassay. The administration of BE resulted in a significant reduction of the AVP level in the amygdala in a naloxone-reversible manner. Naloxone (Nal) administered subcutaneously significantly increased the AVP content in the septum. The results revealed that BE and Nal had regionally specific effects on the activity of the vasopressinergic system but not on that of the oxytocinergic system in the brain.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2524402     DOI: 10.1007/bf01952034

Source DB:  PubMed          Journal:  Experientia        ISSN: 0014-4754


  13 in total

1.  Brain RNA and hypophysectomy; a topographical study.

Authors:  W H Gispen; P Schotman; E R de Kloet
Journal:  Neuroendocrinology       Date:  1972       Impact factor: 4.914

2.  Opiate inhibition of peptide release from the neurohumoral terminals of hypothalamic neurones.

Authors:  G Clarke; P Wood; L Merrick; D W Lincoln
Journal:  Nature       Date:  1979-12-13       Impact factor: 49.962

3.  Effect of opioid peptides on the paraventricular nucleus of the guinea pig hypothalamus is mediated by mu-type receptors.

Authors:  J P Wuarin; M Dubois-Dauphin; M Raggenbass; J J Dreifuss
Journal:  Brain Res       Date:  1988-04-05       Impact factor: 3.252

4.  Morphine and opioid peptides reduce paraventricular neuronal activity: studies on the rat hypothalamic slice preparation.

Authors:  Q J Pittman; J D Hatton; F E Bloom
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

5.  The distribution of vasopressin and oxytocin in the rat brain.

Authors:  J Dogterom; F G Snijdewint; R M Buijs
Journal:  Neurosci Lett       Date:  1978-10       Impact factor: 3.046

6.  Does naloxone always act as an opiate antagonist?

Authors:  A A Badawy; M Evans; N F Punjani; C J Morgan
Journal:  Life Sci       Date:  1983       Impact factor: 5.037

7.  Vasopressin-immunoreactive cell bodies in the bed nucleus of the stria terminalis of the rat.

Authors:  F van Leeuwen; R Caffé
Journal:  Cell Tissue Res       Date:  1983       Impact factor: 5.249

8.  Effects of beta-endorphin2-9 on arginine-8-vasopressin and oxytocin levels in hypothalamic and limbic brain regions.

Authors:  F Laczi; M Vecsernyés; G L Kovács; G Szabó; T Janáky; G Telegdy; F A Lásló
Journal:  Brain Res       Date:  1987-02-10       Impact factor: 3.252

9.  Naloxone as a GABA antagonist: evidence from iontophoretic, receptor binding and convulsant studies.

Authors:  R Dingledine; L L Iversen; E Breuker
Journal:  Eur J Pharmacol       Date:  1978-01-01       Impact factor: 4.432

10.  Effect of the opioid peptide beta-endorphin on the in vivo release of vasopressin in rats under various conditions.

Authors:  J A ten Haaf; T B van Wimersma Greidanus; C Maigret; D De Wied
Journal:  Neuroendocrinology       Date:  1986       Impact factor: 4.914

View more
  1 in total

Review 1.  The effects of beta-endorphin: state change modification.

Authors:  Jan G Veening; Henk P Barendregt
Journal:  Fluids Barriers CNS       Date:  2015-01-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.